KR102424758B9 - 오리나무 추출물을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 - Google Patents

오리나무 추출물을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물

Info

Publication number
KR102424758B9
KR102424758B9 KR1020200100747A KR20200100747A KR102424758B9 KR 102424758 B9 KR102424758 B9 KR 102424758B9 KR 1020200100747 A KR1020200100747 A KR 1020200100747A KR 20200100747 A KR20200100747 A KR 20200100747A KR 102424758 B9 KR102424758 B9 KR 102424758B9
Authority
KR
South Korea
Prior art keywords
extract
treating
composition
related disorder
skeleton muscle
Prior art date
Application number
KR1020200100747A
Other languages
English (en)
Other versions
KR102424758B1 (ko
KR20220020477A (ko
Inventor
류재하
이혜진
최성희
Original Assignee
숙명여자대학교산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 숙명여자대학교산학협력단 filed Critical 숙명여자대학교산학협력단
Priority to KR1020200100747A priority Critical patent/KR102424758B1/ko
Priority to PCT/KR2021/010158 priority patent/WO2022035115A1/ko
Priority to US18/018,473 priority patent/US20230270805A1/en
Publication of KR20220020477A publication Critical patent/KR20220020477A/ko
Priority to KR1020220051499A priority patent/KR102410619B1/ko
Priority to KR1020220083246A priority patent/KR102432796B1/ko
Priority to KR1020220083247A priority patent/KR102432797B1/ko
Application granted granted Critical
Publication of KR102424758B1 publication Critical patent/KR102424758B1/ko
Publication of KR102424758B9 publication Critical patent/KR102424758B9/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/30—Other Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
KR1020200100747A 2020-08-11 2020-08-11 오리나무 추출물을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 KR102424758B1 (ko)

Priority Applications (6)

Application Number Priority Date Filing Date Title
KR1020200100747A KR102424758B1 (ko) 2020-08-11 2020-08-11 오리나무 추출물을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물
PCT/KR2021/010158 WO2022035115A1 (ko) 2020-08-11 2021-08-03 오리나무 추출물 또는 이로부터 분리된 화합물을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물 및 이의 용도
US18/018,473 US20230270805A1 (en) 2020-08-11 2021-08-03 A composition comprising an extract of alder tree or the isolated compounds therefrom for treating and preventing skeleton muscle-related disorder and the use thereof
KR1020220051499A KR102410619B1 (ko) 2020-08-11 2022-04-26 오리나무 추출물로부터 분리된 화합물 1을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물
KR1020220083246A KR102432796B1 (ko) 2020-08-11 2022-07-06 오리나무 추출물로부터 분리된 화합물 2를 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물
KR1020220083247A KR102432797B1 (ko) 2020-08-11 2022-07-06 오리나무 추출물로부터 분리된 화합물 3-5를 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020200100747A KR102424758B1 (ko) 2020-08-11 2020-08-11 오리나무 추출물을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물

Related Child Applications (3)

Application Number Title Priority Date Filing Date
KR1020220051499A Division KR102410619B1 (ko) 2020-08-11 2022-04-26 오리나무 추출물로부터 분리된 화합물 1을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물
KR1020220083246A Division KR102432796B1 (ko) 2020-08-11 2022-07-06 오리나무 추출물로부터 분리된 화합물 2를 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물
KR1020220083247A Division KR102432797B1 (ko) 2020-08-11 2022-07-06 오리나무 추출물로부터 분리된 화합물 3-5를 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물

Publications (3)

Publication Number Publication Date
KR20220020477A KR20220020477A (ko) 2022-02-21
KR102424758B1 KR102424758B1 (ko) 2022-07-26
KR102424758B9 true KR102424758B9 (ko) 2023-04-12

Family

ID=80246777

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020200100747A KR102424758B1 (ko) 2020-08-11 2020-08-11 오리나무 추출물을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물
KR1020220051499A KR102410619B1 (ko) 2020-08-11 2022-04-26 오리나무 추출물로부터 분리된 화합물 1을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물
KR1020220083246A KR102432796B1 (ko) 2020-08-11 2022-07-06 오리나무 추출물로부터 분리된 화합물 2를 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물
KR1020220083247A KR102432797B1 (ko) 2020-08-11 2022-07-06 오리나무 추출물로부터 분리된 화합물 3-5를 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물

Family Applications After (3)

Application Number Title Priority Date Filing Date
KR1020220051499A KR102410619B1 (ko) 2020-08-11 2022-04-26 오리나무 추출물로부터 분리된 화합물 1을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물
KR1020220083246A KR102432796B1 (ko) 2020-08-11 2022-07-06 오리나무 추출물로부터 분리된 화합물 2를 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물
KR1020220083247A KR102432797B1 (ko) 2020-08-11 2022-07-06 오리나무 추출물로부터 분리된 화합물 3-5를 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물

Country Status (3)

Country Link
US (1) US20230270805A1 (ko)
KR (4) KR102424758B1 (ko)
WO (1) WO2022035115A1 (ko)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102645399B1 (ko) 2022-07-25 2024-03-11 코스맥스엔에스 주식회사 유스카픽 에시드를 포함하는 근 기능 개선 또는 근육 질환 예방, 개선 또는 치료용 조성물
KR102487069B1 (ko) 2022-10-17 2023-01-10 이주연 황백, 오리나무 및 회향을 포함하는 혼합물의 이중 복합 추출물을 포함하는 항바이러스용 조성물
KR102555401B1 (ko) 2023-01-05 2023-07-13 이주연 황백, 오리나무 및 회향을 포함하는 혼합물의 이중 복합 추출물을 포함하는 코로나 바이러스 억제용 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100950428B1 (ko) * 2008-06-05 2010-04-02 주식회사 알앤엘바이오 바이러스 억제제로서 유용한 디아릴헵타노이드계 화합물
KR100987303B1 (ko) * 2009-12-14 2010-10-12 주식회사 알앤엘바이오 오리나무 유래 디아릴헵타노이드계 화합물을 포함하는 항산화 및 간보호용 조성물
KR20120089118A (ko) * 2011-02-01 2012-08-09 주식회사 엘컴사이언스 오리나무 추출물 또는 그로부터 분리된 화합물을 유효성분으로 포함하는 간 섬유화 억제용 조성물
KR101310285B1 (ko) * 2011-10-12 2013-09-24 심재종 산청목, 오리목, 포공영, 대계, 창이자, 갈화, 지구목 및 갈근을 유효성분으로 함유하는 뇌질환 예방 또는 치료용 약학적 조성물
KR20180131770A (ko) * 2017-06-01 2018-12-11 숙명여자대학교산학협력단 황련 추출물을 함유하는 근육관련 질환의 예방 및 치료용 조성물
KR102205634B1 (ko) * 2019-01-11 2021-01-21 주식회사 에코프로 폼멜트가 접착된 케미컬 필터, 그 제조방법 및 그 제조장치

Also Published As

Publication number Publication date
WO2022035115A1 (ko) 2022-02-17
US20230270805A1 (en) 2023-08-31
KR20220102600A (ko) 2022-07-20
KR102432797B9 (ko) 2023-04-12
KR102432796B9 (ko) 2023-04-12
KR102432797B1 (ko) 2022-08-16
KR102410619B1 (ko) 2022-06-22
KR20220101588A (ko) 2022-07-19
KR102410619B9 (ko) 2023-04-12
KR102424758B1 (ko) 2022-07-26
KR20220061070A (ko) 2022-05-12
KR102432796B1 (ko) 2022-08-16
KR20220020477A (ko) 2022-02-21

Similar Documents

Publication Publication Date Title
KR102424758B9 (ko) 오리나무 추출물을 함유하는 골격근 근육관련 질환의 예방 및 치료용 조성물
EP3609593A4 (en) METHOD TO REDUCE CHLOROPHYLL CO-EXTRACTION BY EXTRACTION OF SELECTED ESSENTIAL OILS AND AROMATIC ISOLATES
IL288395A (en) Mat2a tricyclic inhibitors and methods for use in cancer therapy
SG10201809153WA (en) Muscle atrophy inhibitor containing quercetin glycoside
PT3297433T (pt) Uso de hidroxiapatite como um veículo de elementos nutricionais e extratos vegetais para tratar plantas
IL279784A (en) Improvements to methods and devices and methods and devices for removing skin pigmentation and tattoo ink
EP4043075C0 (en) KN-93 INTENDED FOR USE IN THE PREVENTION AND TREATMENT OF PSORIASIS
IL277315B (en) Method and preparations for treating the corona virus infection
IL282654A (en) Method and medicament for treating cancer that does not respond to a PD-1/PD-L1 signaling inhibitor
ZA202206163B (en) Methods of treating coronavirus
MX2020006224A (es) Metodos y terapia combinada para el tratamiento del cancer.
PL3897188T3 (pl) Algowy składnik pasz do kontroli skutków kokcydiozy i nekrotycznego zapalenia jelit u drobiu
IL289251A (en) Methods and preparations for the treatment of pancreatic cancer
EP4103206A4 (en) METHOD FOR TREATING AND PREVENTING ENGRAFTMENT ARRHYTHMIA
GB201913122D0 (en) Compositions and methods for treatment of cholangiocarcinoma
EP3043808A4 (en) A composition comprising an extract of combined herbs consisting of acanthopanax koreanum nakai and crinum asiaticum var. japonicum showing preventing activity of baldness and stimulating activity of hair growth
ZA202103193B (en) Single-dose use of a composition comprising a particular mixture of grape extract and blueberry extract
EP4149508A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF CANCER
EP4165140A4 (en) EXTRACTION PROCESS
GB202005986D0 (en) Methods and compositions for treating and combatting tuberulosis
GB202005987D0 (en) Methods and compositions for treating and combatting sars-cov and sars-cov-2
IL288524A (en) Methods of treatment or prevention of eczema
GB202019361D0 (en) Energy extraction system and method of use
IL312281A (en) Methods for treating head and neck cancer with hemp extract
EP4104851C0 (en) PHARMACEUTICAL COMPOSITION CONTAINING A SURFACTANT AND NATURAL PLANT EXTRACTS FOR THE PREVENTION AND TREATMENT OF CORONAVIRUS

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
G170 Re-publication after modification of scope of protection [patent]